Jump to navigation
Yesterday, the FDA called for comments to help the United Nation’s World Health Organization (WHO) decide whether 17 controversial drugs should face international restrictions under the 1971 Convention on Psychotropic Substances.
Out of the listed substances, cannabidiol (CBD) was the only one that the FDA called beneficial. The agency issued the following statement:
GW Pharmaceuticals plc (GWPH) has once again changed the landscape of the cannabis industry as the company reported its second positive Stage 3 Clinical trial for its Epidiolex product.
The results for this trial were for the treatment of Lennox-Gastaut syndrome (LGS) and Epidiolex was able to significantly reduce the number of drop seizures over a 14-week period when compared to a placebo.
Yesterday, Chuck Rosenberg, who is the new head of the Drug Enforcement Agency (DEA), made the following statement at the agency’s headquarters.
“Heroin is clearly more dangerous than marijuana.”
Painkillers have become a serious issue in the United States. During the past 15 years, America has seen a tremendous growth in both the sales of prescription opiates and the number of people who die each year from abusing them. According to the Center for Disease Control (CDC), painkillers accounted for 60% of all overdose deaths in 2013. Researchers from the RAND Corporation and the University of California-Irvine (UCI) may have found the answer and that is marijuana.
During the first five months of 2015, the number of people who have died from synthetic marijuana has tripled when compared to the same period last year. On Thursday, the Centers for Disease Control and Prevention (CDC) issued a report that said 15 people have died this year from synthetic marijuana and that the number of calls to poison control centers has also skyrocketed.
Nemus Bioscience Inc. (NMUS) is a biopharmaceutical company focused on developing cannabis-based therapeutics for the treatment of a variety of diseases.
The biotech sector has been and will continue to be one greatest beneficiaries of the growth in the cannabis industry. The sector is comprised of the most credible cannabis companies; some of which trade on the NASDAQ. There are also a number of biotech companies trading on the over-the-counter (OTC) exchange. These companies are in their developmental stage and are thus naturally speculative in nature. However, with big risk comes big reward.
Today, Smart Approaches to Marijuana will present a plan to officials in Washington that aims to ease restrictions on scientific research into marijuana. The group was co-founded by former United States Congressman Patrick Kennedy and opposes the legalization of marijuana.
The Food and Drug Administration (FDA) announced that products which contain cannabidiol (CBD) cannot be sold as dietary supplements. The agency, however, left open the possibility that would it consider contrary evidence.
On Monday, Pennsylvania Governor Tom Wolf hosted marijuana supporters at his residence for what he described as a chance to get the facts out. This comes after State Representative Matt Baker stated that he will not advance Senate Bill 3 because cannabis is not approved by the FDA.
Processing, please wait. This may take up to 15 seconds to complete.
Please do not close your browser.